Key result
Transcatheter aortic valve implantation resulted in significantly lower activation of complement, granulocytes, monocytes, and eosinophils compared to surgical replacement (P<0.01).
Why the study?
Does TAVI reduce the inflammatory response compared to SAVR in patients undergoing aortic valve replacement?
Population
36 patients undergoing aortic valve replacement
Comparison
Transcatheter aortic valve implantation vs Surgical aortic valve replacement (SAVR) (n=18)
Design
Cohort
Follow-up
per- and postoperatively
Authors
Loading...
TAVI linked to lower inflammatory activation than SAVR; leaves open impact on outcomes and need for randomized confirmation.
RCT (n=36)
Does TAVI reduce the inflammatory response compared to SAVR in patients undergoing aortic valve replacement?
p-value: p=<0.01
TAVI is associated with a significantly lower systemic inflammatory response compared to SAVR, though myocardial injury markers (troponin T) and IL-6 are similar.
Fiane et al. (2017) conducted an RCT in Aortic valve disease requiring replacement (n=36). Transcatheter aortic valve implantation (TAVI) vs. Surgical aortic valve replacement (SAVR) was evaluated on Inflammatory response (areas under the curve for inflammatory markers including complement, granulocytes, monocytes, and eosinophils) (p=<0.01). Transcatheter aortic valve implantation resulted in significantly lower activation of complement, granulocytes, monocytes, and eosinophils compared to surgical replacement (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: